Promotion of miR-221-5p on the Sensitivity of Gastric Cancer Cells to Cisplatin and Its Effects on Cell Proliferation and Apoptosis by Regulating DDR1 [Retraction]
Jiang X, Jiang M, Guo S, Cai P, Wang W, Li Y. Onco Targets Ther. 2020;13:2333–2345.
At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. On review of the study data the authors found that 23 of the 27 squamous cell carcinomas reported in Table 1 had been mistakenly identified as coming from gastric cancer patients. These patients were subsequently identified as esophageal cancer patients and should not have been included in the data analysis. As a result, the authors have determined the findings of the study are invalid and requested for the article to be retracted.
The authors wish to apologise for this error.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.